Abstract
Purpose
New-onset atrial fibrillation (NOAF) is common and associated with increased morbidity and mortality. However, its clinical importance and management in critically ill patients are not well described. The aim of this scoping review is to assess the epidemiology and management strategies of NOAF during critical illness.
Method
The review was conducted in accordance with the PRISMA extension for scoping reviews. We searched PubMed, EMBASE and the Cochrane Library for studies assessing the incidence, outcome and management strategies of NOAF in adult critically ill patients. The quality of evidence was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach.
Results
A total of 99 studies were included, of which 79 were observational and 20 were interventional. The incidence of NOAF varied from 1.7% to 43.9% with considerable inter-population variation (very low quality of evidence). Commonly identified risk factors for NOAF included higher age, cardiovascular comorbidities and sepsis. The occurrence of NOAF was associated with adverse outcomes, including stroke, prolonged length of stay and mortality (very low quality of evidence). We found limited data on the optimal management strategy with no evidence for firm benefit or harm for any intervention (very low/low quality of evidence).
Conclusions
The definition and incidence of NOAF in critically ill patients varied considerably and many risk factors were identified. NOAF seemed to be associated with adverse outcomes, but data were very limited and current management strategies are not evidence-based.
Similar content being viewed by others
References
Chugh SS, Havmoeller R, Narayanan K, Singh D et al (2014) Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation 129:837–847
Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S (2014) Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol 6:213–220
Stewart S, Hart CL, Hole DJ, McMurray JJ (2002) A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 113:359–364
McIntyre WF, Um KJ, Cheung CC, Belley-Cote EP et al (2018) Atrial fibrillation detected initially during acute medical illness: a systematic review. Eur Heart J Acute Cardiovasc Care 8:130–141
Bosch NA, Cimini J, Walkey AJ (2018) Atrial fibrillation in the ICU. Chest 154:1424–1434
Prystowsky EN, Padanilam BJ, Fogel RI (2015) Treatment of atrial fibrillation. JAMA 314:278–288
Sibley S, Muscedere J (2015) New-onset atrial fibrillation in critically ill patients. Can Respir J 22:179–182
Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H et al (2018) PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 169:467–473
Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D et al (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928
Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919
Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, Vist GE, Falck-Ytter Y et al (2011) GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 64:401–406
Ambrus DB, Benjamin EJ, Bajwa EK, Hibbert KA, Walkey AJ (2015) Risk factors and outcomes associated with new-onset atrial fibrillation during acute respiratory distress syndrome. J Crit Care 30:994–997
Annane D, Sebille V, Duboc D, Le Heuzey JY, Sadoul N, Bouvier E, Bellissant E (2008) Incidence and prognosis of sustained arrhythmias in critically ill patients. Am J Respir Crit Care Med 178:20–25
Arrigo M, Ishihara S, Feliot E, Rudiger A, Deye N, Cariou A, Guidet B, Jaber S, Leone M, Resche-Rigon M, Vieillard Baron A et al (2018) New-onset atrial fibrillation in critically ill patients and its association with mortality: a report from the FROG-ICU study. Int J Cardiol 266:95–99
Arora S, Lang I, Nayyar V, Stachowski E, Ross DL (2007) Atrial fibrillation in a tertiary care multidisciplinary intensive care unit–incidence and risk factors. Anaesth Intensive Care 35:707–713
Artucio H, Pereira M (1990) Cardiac arrhythmias in critically ill patients: epidemiologic study. Crit Care Med 18:1383–1388
Aydogdu M, Hanazay C, Aldag Y, Baha A et al (2017) Effects of atrial fibrillation on intensive care unit outcomes in patients with respiratory failure. J Med Surg Intensive Care Med 8:32–38
Chelazzi C, Villa G, Giugni D, De Gaudio AR (2011) Atrial fibrillation in the surgical critical patients: associated clinical factors and outcome. Eur J Anaesthesiol 28:184 (Abstract)
Fernando Montenegro Sa F, Ruivo C, Antunes A, Jesus C et al (2016) Predicting atrial fibrillation in critically ill patients admitted in a general intensive care unit: is BNP really helpful? Eur J Heart Fail 18:205 (Abstract)
Ganguly S, Brown T, Pritchett C, Edie S, Allan P, Spivey M (2015) Atrial fibrillation in intensive care. Intensive Care Med Exp 3:A209 (Abstract)
Goodman S, Shirov T, Weissman C (2007) Supraventricular arrhythmias in intensive care unit patients: short and long-term consequences. Anesth Analg 104:880–886
Jenkins SA, Griffin R (2016) New-onset atrial fibrillation in intensive care: incidence, management and outcome. Crit Care 20:143 (Abstract)
Kanji S, Williamson DR, Yaghchi BM, Albert M, McIntyre L (2012) Epidemiology and management of atrial fibrillation in medical and noncardiac surgical adult intensive care unit patients. J Crit Care 27:326.e1–326.e8
Makrygiannis SS, Margariti A, Rizikou D, Lampakis M, Vangelis S et al (2014) Incidence and predictors of new-onset atrial fibrillation in noncardiac intensive care unit patients. J Crit Care 29:697.e691–697.e695
Makrygiannis SS, Rizikou D, Patsourakos NG, Lampakis M et al (2018) New-onset atrial fibrillation and clinical outcome in non-cardiac intensive care unit patients. Aust Crit Care 31:274–277
Moss TJ, Calland JF, Enfield KB, Gomez-Manjarres DC et al (2017) New-onset atrial fibrillation in the critically ill. Crit Care Med 45:790–797
Nakanishi M, Kuriyama A, Kaihara T (2015) Incidence and prognosis of new-onset atrial fibrillation in a mixed ICU: an observational study. Crit Care Med 43:23–24 (Abstract)
Nietupski R, Bellamy C, Miano T, Mikkelsen M, Candeloro C (2014) Continuation of amiodarone at discharge for new-onset atrial fibrillation in critically ill patients. Crit Care Med 42:A1403 (Abstract)
Schoaps R, Donovan J, Hazard S, Karamchandani K (2016) Anticoagulation on hospital discharge in critically ill patients with new-onset atrial fibrillation. Crit Care Med 44:128 (Abstract)
Shaver CM, Chen W, Janz DR, May AK, Bernard GR, Darbar D et al (2015) Atrial fibrillation is an independent predictor of mortality in critically ill patients. Crit Care Med 43:2104–2111
Sleeswijk ME, Tulleken JE, Van Noord T, Meertens JH, Ligtenberg JJ et al (2008) Efficacy of magnesium-amiodarone step-up scheme in critically ill patients with new-onset atrial fibrillation: a prospective observational study. J Intensive Care Med 23:61–66
Tasdemir G, Girgin NK, Kaderli AA, Cizmeci E, Iscimen R, Kahveci F et al (2015) Arrhythmia incidence and risk factors in critically ill patients. Crit Care 19:54 (Abstract)
Tober K, Quasim T, Kinsella J (2012) Atrial fibrillation; haemodynamics and mortality in postoperative patients on a general intensive care unit. Intensive Care Med 38:A0520 (Abstract)
Trottier S, Bowie D, Stovall M (2012) Acute atrial fibrillation in the ICU: therapeutic interventions and hospital course. Crit Care Med 40:A286 (Abstract)
Clayton B, Ball S, Read J, Waddy S (2018) Risk of thromboembolism in patients developing critical illness-associated atrial fibrillation. Clin Med 18:282–287
Moskowitz A, Chen KP, Cooper AZ, Chahin A et al (2017) Management of atrial fibrillation with rapid ventricular response in the intensive care unit: a secondary analysis of electronic health record data. Shock 48:436–440
Christian SA, Schorr C, Ferchau L, Jarbrink ME, Parrillo JE, Gerber DR (2008) Clinical characteristics and outcomes of septic patients with new-onset atrial fibrillation. J Crit Care 23:532–536
Guenancia C, Binquet C, Laurent G, Vinault S, Bruyere R, Prin S et al (2014) Incidence and predictors of new-onset atrial fibrillation in septic shock patients in a medical ICU: data from 7-day Holter ECG monitoring. PLoS One 10:e0127168
Jaffer F, Anand S, Ajay-Obe A, Parbtani R, Doraiswamy V, Malo J (2016) Use of amiodarone in management of atrial tachyarrhythmia in septic shock. Chest 150:A361 (Abstract)
Kane S, Hanes S (2014) Impact of hydrocortisone on atrial fibrillation in septic shock. Crit Care Med 42:A1588 (Abstract)
Klein Klouwenberg PM, Kuipers S, Ong PS, Peelen LM, Bonten MJ et al (2017) Incidence, risk factors and outcomes of new-onset atrial fibrillation in critically ill patients with sepsis. A cohort study. Am J Respir Crit Care Med 195:205–211
Koyfman L, Brotfain E, Kutz R, Frenkel A, Schwartz A, Boniel A et al (2015) Epidemiology of new-onset paroxysmal atrial fibrillation in the general intensive care unit population and after discharge from ICU. A retrospective epidemiological study. Anaesthesiol Intensive Ther 47:309–314
Launey Y, Lasocki S, Asehnoune K, Gaudriot B, Chassier C, Cinotti R et al (2017) Impact of low-dose hydrocortisone on the incidence of atrial fibrillation in patients with septic shock. J Intensive Care Med. https://doi.org/10.1177/0885066617696847
Lewis O, Ngwa J, Gillum RF, Davis W, Poddar V, Adams GR et al (2016) Incidence, risk factors and outcomes of new onset supraventricular arrhythmias in African American patients with severe sepsis. Ethn Dis 26:205–212
Liu WC, Lin WY, Lin CS, Huang HB, Lin TC, Cheng SM, Yang SP et al (2016) Prognostic impact of restored sinus rhythm in patients with sepsis and new-onset atrial fibrillation. Crit Care 20:373
Marinheiro AR, Amador P, Ribeiro R, Alves I, Domingos G et al (2016) Incidence, management and impact of atrial fibrillation in septic shock. Eur Heart J 5:60–61
Meierhenrich R, Steinhilber E, Eggermann C, Weiss M, Voglic S et al (2010) Incidence and prognostic impact of new-onset atrial fibrillation in patients with septic shock: a prospective observational study. Crit Care 14:R108
Salman S, Bajwa A, Gajic O, Afessa B (2008) Paroxysmal atrial fibrillation in critically ill patients with sepsis. J Intensive Care Med 23:178–183
Seemann A, Boissier F, Razazi K, Carteaux G, de Prost N et al (2015) New-onset supraventricular arrhythmia during septic shock: prevalence, risk factors and prognosis. Ann Intensive Care 5:27
Shah A, Pillai MV, Gandhi U, Eden E, Shapiro J (2014) New-onset atrial fibrillation/atrial flutter in medical intensive care unit (MICU) patients with severe sepsis is associated with stroke and increased mortality. Am J Respir Crit Care Med 189:A3114 (Abstract)
Swamy L, Ambrus DB, Walkey AJ (2015) Electrocardiographic predictors of new-onset atrial fibrillation among critically ill patients with sepsis: a case-control study. Am J Respir Crit Care Med 191:A6256 (Abstract)
Walkey AJ, Wiener RS, Ghobrial JM, Curtis LH, Benjamin EJ (2011) Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis. JAMA 306:2248–2254
Walkey AJ, Greiner MA, Heckbert SR, Jensen PN, Piccini JP et al (2013) Atrial fibrillation among medicare beneficiaries hospitalized with sepsis: incidence and risk factors. Am Heart J 165:949–955
Walkey AJ, Hammill BG, Curtis LH, Benjamin EJ (2014) Long-term outcomes following development of new-onset atrial fibrillation during sepsis. Chest 146:1187–1195
Walkey AJ, Evans SR, Winter MR, Benjamin EJ (2016) Practice patterns and outcomes of treatments for atrial fibrillation during sepsis: a propensity-matched cohort study. Chest 149:74–83
Wells GL, Morris PE (2011) Incidence and prognosis of atrial fibrillation in patients with sepsis. Cardiol Res 2:293–297
Cheng CA, Cheng CG, Lin HC, Lee JT, Lin HC, Cheng CC et al (2017) New-onset atrial fibrillation-related ischemic stroke occurring after hospital discharge in septicemia survivors. QJM 110:453–457
Bender JS (1996) Supraventricular tachyarrhythmias in the surgical intensive care unit: an under-recognized event. Am Surg 62:73–75
Brathwaite D, Weissman C (1998) The new onset of atrial arrhythmias following major noncardiothoracic surgery is associated with increased mortality. Chest 114:462–468
Brown M, Nassoiy S, Chaney W, Plackett TP, Blackwell RH et al (2018) Impact and treatment success of new-onset atrial fibrillation with rapid ventricular rate development in the surgical intensive care unit. J Surg Res 229:66–75
Chelazzi C, Giugni D, Villa G, De Gaudio AR (2012) Postoperative atrial fibrillation and sepsis. Eur J Anaesthesiol 29:181 (Abstract)
Gerlach AT, Kane-Gill SL, Dasta JF, Steinberg S, Martin LC, Cook CH (2008) Diltiazem versus amiodarone for new-onset atrial arrhythmias in non-cardiac post surgical patients: a cohort study. Crit Care Shock 11:94–106
Knotzer H, Mayr A, Ulmer H, Lederer W, Schobersberger W et al (2000) Tachyarrhythmias in a surgical intensive care unit: a case-controlled epidemiologic study. Intensive Care Med 26:908–914
Seguin P, Signouret T, Laviolle B, Branger B, Malledant Y (2004) Incidence and risk factors of atrial fibrillation in a surgical intensive care unit. Critical Care Med 32:722–726
Xia VW, Worapot A, Huang S, Dhillon A, Gudzenko V, Backon A et al (2015) Postoperative atrial fibrillation in liver transplantation. Am J Transpl 15:687–694
Wenner JB, Bryson GL, Redpath CJ (2015) Peri-operative atrial fibrillation (POAF) complicating non-cardiac surgery: a case–control pilot study. Eur Heart J 36:742 (Abstract)
Yoshida T, Uchino S, Yokota T, Fujii T, Uezono S, Takinami M (2018) The impact of sustained new-onset atrial fibrillation on mortality and stroke incidence in critically ill patients: a retrospective cohort study. J Crit Care 44:267–272
Yokota T, Uchino S, Yoshida T, Fujii T, Takinami M (2018) Predictors for sustained new-onset atrial fibrillation in critically ill patients: a retrospective observational study. J Anesth 32:681–687
Bilotta F, Pizzichetta F, Fiorani L, Paoloni FP, Delfini R, Rosa G (2009) Risk index for peri-operative atrial fibrillation in patients undergoing open intracranial neurosurgical procedures. Anaesthesia 64:503–507
Duby JJ, Heintz SJ, Bajorek SA, Heintz BH, Durbin-Johnson BP et al (2017) Prevalence and course of atrial fibrillation in critically ill trauma patients. J Intensive Care Med 32:140–145
Hadjizacharia P, O’Keeffe T, Brown CV, Inaba K, Salim A et al (2011) Incidence, risk factors, and outcomes for atrial arrhythmias in trauma patients. Am Surg 77:634–639
Seguin P, Laviolle B, Maurice A, Leclercq C, Malledant Y (2006) Atrial fibrillation in trauma patients requiring intensive care. Intensive Care Med 32:398–404
Amar D, Zhang H, Leung DH, Roistacher N, Kadish AH (2002) Older age is the strongest predictor of postoperative atrial fibrillation. Anesthesiology 96:352–356
Amar D, Zhang H, Heerdt PM, Park B, Fleisher M, Thaler HT (2005) Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein. Chest 128:3421–3427
Amar D, Goenka A, Zhang H, Park B, Thaler HT (2006) Leukocytosis and increased risk of atrial fibrillation after general thoracic surgery. Ann Thorac Surg 82:1057–1061
Amar D, Zhang H, Shi W, Downey RJ, Bains MS, Park BJ, Flores R et al (2012) Brain natriuretic peptide and risk of atrial fibrillation after thoracic surgery. J Thorac Cardiovasc Surg 144:1249–1253
Basting A, Bullard H, Sokol S, Shahul S, Tung A (2016) Effect of bronchodilator therapy on postoperative atrial fibrillation after thoracic surgery. Crit Care Med 44:112 (Abstract)
Imperatori A, Mariscalco G, Riganti G, Rotolo N, Conti V, Dominioni L (2012) Atrial fibrillation after pulmonary lobectomy for lung cancer affects long-term survival in a prospective single-center study. J Cardiothorac Surg 7:4
Michalopoulou H, Stamatis PS, Michaloliakou M, Baltagiannis N et al (2012) Atrial fibrillation following major noncardiac thoracic surgery: significance and impact on morbidity. Crit Care 16:168–169 (Abstract)
Panchabhai TS, Zell K, Budev MM, Wang X, Wazni O, Valapour M (2015) Early post-operative atrial fibrillation in lung transplant recipients: an analysis of risk factors and clinical outcomes. Am J Respir Crit Care Med 191:A1421 (Abstract)
Raghavan D, Gao A, Ahn C, Torres F, Mohanka M, Bollineni S et al (2015) Contemporary analysis of incidence of post-operative atrial fibrillation, its predictors, and association with clinical outcomes in lung transplantation. J Heart Lung Transpl 34:563–570
Bahouth F, Mutlak D, Furman M, Musallam A, Hammerman H, Lessick J et al (2010) Relationship of functional mitral regurgitation to new-onset atrial fibrillation in acute myocardial infarction. Heart 96:683–688
Baumfeld Y, Novack V, Almog Y (2013) Atrial fibrillation in medical intensive care unit patients: characteristics and consequences. Harefuah 152(520–523):564
Carrera P, Thongprayoon C, Cheungpasitporn W, Iyer VN, Moua T (2016) Epidemiology and outcome of new-onset atrial fibrillation in the medical intensive care unit. J Crit Care 36:102–106
Chen AY, Sokol SS, Kress JP, Lat I (2015) New-onset atrial fibrillation is an independent predictor of mortality in medical intensive care unit patients. Ann Pharmacother 49:523–527
Pangrazzi M, Lat I, Kress J (2012) Characterizing the impact of atrial fibrillation in the medical intensive care unit. Crit Care Med 40:188 (Abstract)
Preslaski C, Lat I, Mieure K, Bentley L, Lund J, Hall J, Kress J (2011) The impact of new-onset atrial fibrillation on clinical outcomes in the medical intensive care unit. Crit Care Med 39:168 (Abstract)
Sekhri A, Aronow WS, Sekhri V, Palaniswamy C, Chandy D (2009) Treatment of patients with supraventricular tachyarrhythmias in a medical intensive care unit. Compr Ther 35:188–191
Tongyoo S, Permpikul C, Haemin R, Epichath N (2013) Predicting factors, incidence and prognosis of cardiac arrhythmia in medical, non-acute coronary syndrome, critically ill patients. J Med Assoc Thail 96:S238–S245
Terzano C, Romani S, Conti V, Paone G, Oriolo F, Vitarelli A (2014) Atrial fibrillation in the acute, hypercapnic exacerbations of COPD. Eur Rev Med Pharmacol Sci 18:2908–2917
Amar D, Roistacher N, Rusch VW, Leung DH, Ginsburg I, Zhang H et al (2000) Effects of diltiazem prophylaxis on the incidence and clinical outcome of atrial arrhythmias after thoracic surgery. J Thorac Cardiovasc Surg 120:790–798
Ciszewski P, Tyczka J, Nadolski J, Roszak M, Dyszkiewicz W (2013) Comparative efficacy and usefulness of acebutolol and diltiazem for the prevention of atrial fibrillation during perioperative time in patients undergoing pulmonary resection. Thorac Cardiovasc Surg 61:365–372
Khalil MA, Al-Agaty AE, Ali WG, Abdel Azeem MS (2013) A comparative study between amiodarone and magnesium sulfate as antiarrhythmic agents for prophylaxis against atrial fibrillation following lobectomy. J Anesth 27:56–61
Mieghem W, Tits G, Demuynck K, Lacquet L, Deneffe G et al (1996) Verapamil as prophylactic treatment for atrial fibrillation after lung operations. Ann Thorac Surg 61:1083–1085
Tisdale JE, Wroblewski HA, Wall DS, Rieger KM, Hammoud ZT et al (2009) A randomized trial evaluating amiodarone for prevention of atrial fibrillation after pulmonary resection. Ann Thorac Surg 88:886–893
Tisdale JE, Wroblewski HA, Wall DS, Rieger KM, Hammoud ZT et al (2010) A randomized, controlled study of amiodarone for prevention of atrial fibrillation after transthoracic esophagectomy. J Thorac Cardiovasc Surg 140:45–51
Andrivet P, Boubakri E, Dove PJ, Mach V, Vu Ngoc C (1994) A clinical study of amiodarone as a single oral dose in patients with recent-onset atrial tachyarrhythmia. Eur Heart J 15:1396–1402
Andrivet P, Mach V, Gnoc CV (1993) A clinical study of intravenous cibenzoline in selected patients with recent-onset atrial tachyarrhythmia. Chest 103:1515–1519
Barranco F, Sanchez M, Rodriguez J, Guerrero M (1994) Efficacy of flecainide in patients with supraventricular arrhythmias and respiratory insufficiency. Intensive Care Med 20:42–44
Chapman MJ, Moran JL, O’Fathartaigh MS, Peisach AR, Cunningham DN (1993) Management of atrial tachyarrhythmias in the critically ill: a comparison of intravenous procainamide and amiodarone. Intensive Care Med 19:48–52
Faniel R, Schoenfeld P (1983) Efficacy of i.v. amiodarone in converting rapid atrial fibrillation and flutter to sinus rhythm in intensive care patients. Eur Heart J 4:180–185
Moran JL, Gallagher J, Peake SL, Cunningham DN, Salagaras M et al (1995) Parenteral magnesium sulfate versus amiodarone in the therapy of atrial tachyarrhythmias: a prospective, randomized study. Crit Care Med 23:1816–1824
Noc M, Stajer D, Horvat M (1990) Intravenous amiodarone versus verapamil for acute conversion of paroxysmal atrial fibrillation to sinus rhythm. Am J Cardiol 65:679–680
Platia EV, Michelson EL, Porterfield JK, Das G (1990) Intravenous esmolol versus verapamil for prompt treatment of atrial fibrillation or flutter. Am J Cardiol 63:925–929
Varriale P, Sedighi A (2000) Acute management of atrial fibrillation and atrial flutter in the critical care unit: should it be ibutilide? Clin Cardiol 23:265–268
Balser JR, Martinez EA, Winters BD, Perdue PW, Clarke AW et al (1998) Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias. Anesthesiology 89:1052–1059
Iberti TJ, Benjamin E, Paluch TA, Gentili DR, Gabrielson GV (1986) Use of constant-infusion verapamil for the treatment of postoperative supraventricular tachycardia. Crit Care Med 14:283–284
Karth GD, Geppert A, Haumer M, Neunteufl T, Innerhofer P et al (2001) Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias. Crit Care Med 29:1149–1153
Davey MJ, Teubner D (2005) A randomized controlled trial of magnesium sulfate, in addition to usual care, for rate control in atrial fibrillation. Ann Emerg Med 45:347–353
Siu CW, Lau CP, Lee WL, Lam KF, Tse HF (2009) Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation. Crit Care Med 37:2174–2179
Boos CJ, Anderson RA, Lip GY (2006) Is atrial fibrillation an inflammatory disorder? Eur Heart J 27:136–149
Kourliouros A, Savelieva I, Kiotsekoglou A, Jahangiri M, Camm J (2009) Current concepts in the pathogenesis of atrial fibrillation. Am Heart J 157:243–252
Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: Framingham study. Stroke 22:983–988
Odutayo A, Wong CX, Hsiao AJ, Hopewell S, Altman DG, Emdin CA (2016) Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ 354:i4482
Clark DM, Plumb VJ, Epstein AE, Kay GN (1997) Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol 30:1039–1045
McCollam PL, Parker RB, Beckman KJ, Hariman RJ, Bauman JL (1989) Proarrhythmia: a paradoxic response to antiarrhythmic agents. Pharmacotherapy 9:144–153
Krishnan V, Murray P (2003) Pharmacologic issues in the critically ill. Clin Chest Med 24:671–688
Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B et al (2016) 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37:2893–2962
Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O et al (2002) A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347:1834–1840
Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y et al (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:1825–1833
Vieillard-Baron A, Boyd J (2018) Non-antiarrhythmic interventions in new onset and paroxysmal sepsis-related atrial fibrillation. Intensive Care Med 44:94–97
Guo Y, Lip GY, Apostolakis S (2012) Inflammation in atrial fibrillation. J Am Coll Cardiol 60:2263–2270
Labbe V, Ederhy S, Fartoukh M, Cohen A (2016) Erratum: should we administrate anticoagulants to critically ill patients with new onset supraventricular arrhythmias? Arch Cardiovasc Dis 109:656–658
Geerts W, Selby R (2003) Prevention of venous thromboembolism in the ICU. Chest 124:357–363
Funding
MW’s salary is paid by the Research Council of Rigshospitalet.
Author information
Authors and Affiliations
Contributions
MW, NH, AP and MHM contributed to the study design. MW and NH contributed to the study selection. MW performed the data extraction. All the authors contributed to the revision of the manuscript.
Corresponding author
Ethics declarations
Conflicts of interest
The authors have received no specific funding for this study. The Department of Intensive Care at Rigshospitalet receives support for other research projects from Ferring Pharmaceuticals, Denmark; and the Novo Nordisk Foundation, Denmark.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wetterslev, M., Haase, N., Hassager, C. et al. New-onset atrial fibrillation in adult critically ill patients: a scoping review. Intensive Care Med 45, 928–938 (2019). https://doi.org/10.1007/s00134-019-05633-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-019-05633-x